Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
NCT00134745
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Turner Syndrome
Interventions
DRUG:
estradiol
Sponsor
Line Cleemann
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]